Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.56M Sell
413,880
-2,120
-0.5% -$13.1K 0.06% 296
2025
Q4
$2.8M Buy
416,000
+51,900
+14% +$389K 0.08% 248
2025
Q3
$2.97M Buy
+364,100
New +$2.72M 0.08% 265

Other funds holding INGN

CSM Advisors's INGN Position: Q1 2026 in Review

CSM Advisors reduced its Inogen (INGN) stake by 0.51% in Q1 2026, selling an estimated $13.1K and leaving 413,880 shares worth $2.56M. The position accounts for 0.06% of the portfolio, ranked #296.

CSM Advisors first reported a position in INGN in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.97M in Q3 2025. 126 funds tracked by Wall St. Rank hold INGN as of Q1 2026.

  • CSM Advisors held 413,880 shares of Inogen worth $2.56M as of Q1 2026.
  • CSM Advisors sold 2,120 Inogen shares in Q1 2026, an estimated $13.1K.
  • Inogen made up 0.06% of CSM Advisors's portfolio in Q1 2026, its #296 holding.
  • CSM Advisors first reported a position in Inogen in Q3 2025 and has held it in 3 quarters since.
  • CSM Advisors's Inogen position peaked at $2.97M in Q3 2025.
  • 126 funds tracked by Wall St. Rank held Inogen as of Q1 2026.

Based on CSM Advisors's 13F filing for Q1 2026, filed 15 May 2026.